Medline Industries Recalls Reprocessed Webster CS Catheters Due to Potential Residual Material
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries, LP has issued a Class I recall for 228 reprocessed Webster CS Catheters that may contain residual material particles, posing a risk of embolism or infection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Medline Industries, LP has initiated a voluntary Class I recall of specific lots of Medline ReNewal Reprocessed Webster CS Catheters. The recall was triggered by the discovery that these reprocessed devices may contain small particles of residual material. The FDA has classified this as a Class I recall, indicating that the use of these devices could cause serious adverse health consequences or death.
Which Products Are Affected
A total of 228 units distributed nationwide in the United States are affected. The recall includes the following models and lot numbers (EP250429 and EP250808 for all listed):
- Webster CS Catheter 10 Electrodes 2-8-2mm Spacing w/AutoID w/ EZ Steer: Model BD710DF282CRH (UDI-DI 10197344044023)
- Webster CS Catheter 10 Electrodes, 2-8-2mm Spacing w/ EZ Steer: Model BD710DF282RRH (UDI-DI 10197344044030)
- Webster CS Catheter 10 Electrodes, 2-8-2mm Spacing w/ EZ Steer: Model BD710FJ282RRH (UDI-DI 10197344044054)
- Webster CS Catheter 10 Electrodes, 2-8-2mm Spacing w/AutoID w/ EZ Steer: Model BD710FJ282CRH (UDI-DI case 40197344044048; ea 10197344044047)
What You Should Do
Medline Industries notified affected customers via letter starting December 22, 2025. Healthcare facilities and providers should immediately identify and quarantine any affected catheters from the specified lots. Facilities should follow the instructions provided in the firm's notification letter for the return or disposal of the products. For further information, facilities can contact Medline Industries, LP directly at their Northfield, IL headquarters.
Why This Matters
The use of catheters containing residual material poses significant health risks, including inflammatory responses, systemic infections, or thrombus reactions. These conditions may lead to life-threatening complications such as cerebral embolism, pulmonary embolism, or deep vein thrombosis.
Source
Information provided by the FDA under recall number Z-1319-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.